vs

Side-by-side financial comparison of APi Group Corp (APG) and ResMed (RMD). Click either name above to swap in a different company.

APi Group Corp is the larger business by last-quarter revenue ($2.0B vs $1.4B, roughly 1.4× ResMed). ResMed runs the higher net margin — 27.6% vs 2.9%, a 24.7% gap on every dollar of revenue. On growth, APi Group Corp posted the faster year-over-year revenue change (11.7% vs 11.0%). Over the past eight quarters, ResMed's revenue compounded faster (7.9% CAGR vs 7.0%).

X.AI Corp., doing business as xAI, is an American company working in the area of artificial intelligence (AI), social media and technology that is a wholly owned subsidiary of American aerospace company SpaceX. Founded by Elon Musk in 2023, the company's flagship products are the generative AI chatbot named Grok and the social media platform X, the latter of which they acquired in March 2025.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

APG vs RMD — Head-to-Head

Bigger by revenue
APG
APG
1.4× larger
APG
$2.0B
$1.4B
RMD
Growing faster (revenue YoY)
APG
APG
+0.7% gap
APG
11.7%
11.0%
RMD
Higher net margin
RMD
RMD
24.7% more per $
RMD
27.6%
2.9%
APG
Faster 2-yr revenue CAGR
RMD
RMD
Annualised
RMD
7.9%
7.0%
APG

Income Statement — Q1 FY2026 vs Q4 FY2026

Metric
APG
APG
RMD
RMD
Revenue
$2.0B
$1.4B
Net Profit
$57.0M
$392.6M
Gross Margin
31.3%
61.8%
Operating Margin
5.2%
34.6%
Net Margin
2.9%
27.6%
Revenue YoY
11.7%
11.0%
Net Profit YoY
13.9%
EPS (diluted)
$0.12
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APG
APG
RMD
RMD
Q2 26
$1.4B
Q1 26
$2.0B
Q4 25
$2.1B
$1.4B
Q3 25
$2.1B
$1.3B
Q2 25
$2.0B
$1.3B
Q1 25
$1.7B
$1.3B
Q4 24
$1.9B
$1.3B
Q3 24
$1.8B
$1.2B
Net Profit
APG
APG
RMD
RMD
Q2 26
$392.6M
Q1 26
$57.0M
Q4 25
$97.0M
$392.6M
Q3 25
$93.0M
$348.5M
Q2 25
$77.0M
$379.7M
Q1 25
$35.0M
$365.0M
Q4 24
$67.0M
$344.6M
Q3 24
$69.0M
$311.4M
Gross Margin
APG
APG
RMD
RMD
Q2 26
61.8%
Q1 26
31.3%
Q4 25
32.0%
61.8%
Q3 25
31.3%
61.5%
Q2 25
30.9%
60.8%
Q1 25
31.5%
59.3%
Q4 24
30.9%
58.6%
Q3 24
31.1%
58.6%
Operating Margin
APG
APG
RMD
RMD
Q2 26
34.6%
Q1 26
5.2%
Q4 25
7.7%
34.6%
Q3 25
7.8%
33.4%
Q2 25
7.2%
33.7%
Q1 25
4.9%
33.0%
Q4 24
6.2%
32.5%
Q3 24
7.8%
31.6%
Net Margin
APG
APG
RMD
RMD
Q2 26
27.6%
Q1 26
2.9%
Q4 25
4.6%
27.6%
Q3 25
4.5%
26.1%
Q2 25
3.9%
28.2%
Q1 25
2.0%
28.3%
Q4 24
3.6%
26.9%
Q3 24
3.8%
25.4%
EPS (diluted)
APG
APG
RMD
RMD
Q2 26
$2.68
Q1 26
$0.12
Q4 25
$-1.16
$2.68
Q3 25
$0.20
$2.37
Q2 25
$0.16
$2.58
Q1 25
$0.11
$2.48
Q4 24
$0.05
$2.34
Q3 24
$0.23
$2.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APG
APG
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$645.0M
$1.4B
Total DebtLower is stronger
$2.8B
$663.8M
Stockholders' EquityBook value
$3.5B
$6.3B
Total Assets
$9.0B
$8.5B
Debt / EquityLower = less leverage
0.79×
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APG
APG
RMD
RMD
Q2 26
$1.4B
Q1 26
$645.0M
Q4 25
$912.0M
$1.4B
Q3 25
$555.0M
$1.4B
Q2 25
$432.0M
$1.2B
Q1 25
$460.0M
$932.7M
Q4 24
$499.0M
$521.9M
Q3 24
$487.0M
$426.4M
Total Debt
APG
APG
RMD
RMD
Q2 26
$663.8M
Q1 26
$2.8B
Q4 25
$2.8B
$403.9M
Q3 25
$2.8B
$408.7M
Q2 25
$2.8B
$658.4M
Q1 25
$2.8B
$663.1M
Q4 24
$2.8B
$662.9M
Q3 24
$2.9B
$667.6M
Stockholders' Equity
APG
APG
RMD
RMD
Q2 26
$6.3B
Q1 26
$3.5B
Q4 25
$3.4B
$6.3B
Q3 25
$3.3B
$6.1B
Q2 25
$3.2B
$6.0B
Q1 25
$3.0B
$5.5B
Q4 24
$3.0B
$5.3B
Q3 24
$3.0B
$5.2B
Total Assets
APG
APG
RMD
RMD
Q2 26
$8.5B
Q1 26
$9.0B
Q4 25
$8.9B
$8.5B
Q3 25
$8.7B
$8.3B
Q2 25
$8.5B
$8.2B
Q1 25
$8.1B
$7.6B
Q4 24
$8.2B
$7.1B
Q3 24
$8.2B
$7.2B
Debt / Equity
APG
APG
RMD
RMD
Q2 26
0.11×
Q1 26
0.79×
Q4 25
0.81×
0.06×
Q3 25
0.84×
0.07×
Q2 25
0.87×
0.11×
Q1 25
0.92×
0.12×
Q4 24
0.93×
0.13×
Q3 24
0.96×
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APG
APG
RMD
RMD
Operating Cash FlowLast quarter
$85.0M
Free Cash FlowOCF − Capex
$67.0M
FCF MarginFCF / Revenue
3.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.49×
TTM Free Cash FlowTrailing 4 quarters
$680.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APG
APG
RMD
RMD
Q2 26
Q1 26
$85.0M
Q4 25
$382.0M
$339.7M
Q3 25
$232.0M
$457.3M
Q2 25
$83.0M
$538.8M
Q1 25
$62.0M
$578.7M
Q4 24
$283.0M
$308.6M
Q3 24
$220.0M
$325.5M
Free Cash Flow
APG
APG
RMD
RMD
Q2 26
Q1 26
$67.0M
Q4 25
$356.0M
$311.2M
Q3 25
$201.0M
$414.4M
Q2 25
$56.0M
$508.2M
Q1 25
$50.0M
$557.9M
Q4 24
$265.0M
$288.0M
Q3 24
$198.0M
$307.7M
FCF Margin
APG
APG
RMD
RMD
Q2 26
Q1 26
3.4%
Q4 25
16.8%
21.9%
Q3 25
9.6%
31.0%
Q2 25
2.8%
37.7%
Q1 25
2.9%
43.2%
Q4 24
14.2%
22.5%
Q3 24
10.8%
25.1%
Capex Intensity
APG
APG
RMD
RMD
Q2 26
Q1 26
Q4 25
1.2%
2.0%
Q3 25
1.5%
3.2%
Q2 25
1.4%
2.3%
Q1 25
0.7%
1.6%
Q4 24
1.0%
1.6%
Q3 24
1.2%
1.5%
Cash Conversion
APG
APG
RMD
RMD
Q2 26
Q1 26
1.49×
Q4 25
3.94×
0.87×
Q3 25
2.49×
1.31×
Q2 25
1.08×
1.42×
Q1 25
1.77×
1.59×
Q4 24
4.22×
0.90×
Q3 24
3.19×
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons